Indian doctors are going to use Hospitech designed, manufactured CDP in 10 hospitals
Hospitech-made Cancer Diagnostic Probe (CDP) can determine the extent of metastasis and spread of a cancerous tumor in women’s breasts with high precision. (Photo by Fars news agency)
A delegation comprising Indian investors and surgeons visited the Hospitech capital to be briefed on a domestically-made Cancer Diagnostic Probe (CDP) at Tehran’s Imam Khomeini Hospital.
According to a Monday report by the Fars news agency, the Hospitech CDP has been designed and manufactured by Mohammad Abdolahad, a faculty member of the University of Tehran’s College of Engineering.
The CDP is a medical device, which can determine the extent of metastasis and spread of a cancerous tumor in women’s breasts. It can detect the margin of breast cancer and help remove cancerous outgrowths with high precision.
The cancer margin is the edge or border of the tissue removed in cancer surgery, where cancerous cells could still exist and lead to later recurrence of the disease.
A delegation comprising Indian investors and surgeons is briefed on a Hospitech-made Cancer Diagnostic Probe (CDP) at Tehran’s Imam Khomeini Hospital on January 9, 2023. (Photo by Fars news agency)
The existing method uses frozen sections to detect the margin of cancer and it takes about a full hour to do so. This interval increases the cost of surgery and reduces its speed while causing patients to spend more time under anesthesia.
However, the Hospitech CDP, which has been developed by Abdolahad’s research team, can reduce that time to 15 seconds. The sensitivity of this device has been reported at over 97 percent and it has been used by middle east surgeons for about two years.
Now, after visiting the Hospitech CDP and its functionality, the Indian delegation has indicated its willingness to purchase the equipment and use it in 10 hospitals.
